Lilly(Eli) & Company
NYSE: LLY
$831.54
+$34.09 (+4.3%)
Closing Price on November 8, 2024
LLY Stock Chart and Intraday Price
LLY Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 743,142.26M USD |
| Shares Outstanding | 950,164,000 |
LLY Articles
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 503.90% and currently trading at $798.41. The company has been around since 1876 and the...
Published:
Last Updated:
A stock split divides existing shares into multiple new ones, increasing a given company’s share count and making shares more affordable for those looking to buy in. For the same $10,000...
Published:
It’s no surprise that inflation over the past four years have sent the prices of goods and services steeply spiraling upwards. With certain food staples rising over 40-50%, gas and electricity...
Published:
There is a reason the Schwab US Dividend ETF (NYSEARCA:SCHD) is a top-of-list purchase for investors. It provides one of the easiest ways to buy the biggest dividend growth stocks in the U.S....
Published:
In the ever-changing world of investing, ETFs have become the go-to choice for many novice and seasoned investors. ETFs are “baskets” of stocks. When you buy an ETF, you’re investing in all the...
Published:
Selecting stocks for the long haul can be a challenge. Here is what could be the best-performing stock in 2030 and why.
Published:
The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we need it, to everyday pain remediation or allergy medications, big pharma...
Published:
Diversification is key in today’s investing world. Exchange-traded funds, or ETFs, offer a convenient and affordable way to achieve this. Think of them as baskets filled with a variety of stocks....
Published:
247 Wall St. Key Insights QQQ offers higher growth potential but comes with greater risk due to its reliance on tech stocks. VOO provides broad market exposure with lower risk and steady growth. ...
Published:
Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which I’m going to dive into with a few of these picks. Whether we’re...
Published:
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are for the next decade of growth.
Published:
Jim Cramer is probably the closest thing we have to stock market superstar influencer. The host of CNBC’s “Mad Money” show is entertaining and popular with a broad swath of investors who like...
Published:
Some of the best opportunities can still be found in obesity treatment stocks. Look at Viking Therapeutics (NASDAQ:VKTX), for example. Now trading at $57.80, we strongly believe it could easily rally...
Published:
As the high-growth trade fizzles out in September, even some top-tier secular growth plays will take an outsized hit to the chin. Undoubtedly, several investment themes, including generative AI and...
Published:
Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair. The drug discovery...
Published: